Study details
Enrolling now
Convalescent Plasma Collection and Treatment
West Virginia University
NCT IDNCT04376034ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
240
Study length
about 12 months
Ages
0.0848751172166437+
Locations
1 site in WV
About this study
Researchers are testing whether convalescent plasma can help people recover from COVID-19. Participants will receive either one or two units of plasma, or standard care. The trial will last for 348 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Convalescent Plasma 1 Unit
- 2.Receive Convalescent Plasma 2 Units
- 3.Standard of Care
PhasePhase 3
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Infectious